HOME >> BIOLOGY >> NEWS
Ethical decision-making at bioscience companies

Pharmaceutical and biotech companies, grappling with complex ethical issues (such as stem cell and animal research), say that they are gradually formalizing systematic approaches to ethical decision-making, according to a study published in PLoS Medicine.

Jocelyn Mackie and colleagues (University of Toronto and Keck Graduate Institute of Applied Life Sciences) performed over 100 in-depth, face-to-face interviews with top managers and executives at 13 bioscience companies to learn about bioindustry ethics from their perspective.

The research represents some of the first empirical evidence of how bioscience companies are dealing with ethical issues. Mackie and colleagues' work will be discussed by delegates at the annual international convention of the Biotechnology Industry Association in Chicago April 9-12 (www.bio.org).

Company managers and executives say that they have adopted five approaches to ethical decision-making:

Ethical leadership (e.g. in larger companies, whole departments are dedicated to ethical issues)

External expertise (several companies use external consultants to provide ethics expertise not available internally) Internal ethics mechanisms (e.g. some companies now weigh candidates' ethical values when hiring)

External ethics engagement (e.g. more than half of the companies studied require business partners to match their ethical approaches) Ethics evaluation and reporting mechanisms (a few companies studied have formalized the way they evaluate and report to stakeholders on their ethical commitments).

"Because they operate near the cutting edge of scientific research and development, with processes and products that are often controversial," says Mackie, "the ethical commitment of bioscience companies is regularly called into question."

"Our analysis uncovered five interrelated approaches, each with several mechanisms, used to address e
'"/>

Contact: Andrew Hyde
ahyde@plos.org
44-122-346-3330
Public Library of Science
3-Apr-2006


Page: 1 2

Related biology news :

1. 4th International Conference on Ethical Issues in Biomedical Engineering
2. Ethical and scientific guidelines for study of captive great apes
3. Ethical paradigm: Relating embryonic stem cell use to organ donation
4. Honeybee decision-making ability rivals any department committee
5. Amid growing public concerns, bioscience firms begin formalizing ethical decision-making practices
6. Worth the wait? A neural mechanism related to impulsive decision-making
7. Put science at center of decision-making on third world development, experts tell UN
8. Perceptual decision-making hub pinpointed in human brain
9. Nottingham biosciences million pound injection
10. Lehigh receives $1.8 million from Howard Hughes Medical Institute for bioscience education
11. New frontiers in molecular bioscience topic of UD symposium

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/7/2019)... ... May 07, 2019 , ... ... Long Beach Convention and Entertainment Center from May 15- 17. At booth #226, ... solutions. These include flexible software, biometric hardware, mobile apps, specialized industry solutions, advanced ...
(Date:5/2/2019)... ... April 30, 2019 , ... Global ... announces today that Holotype HLA and other Omixon products will be featured in ... Immunogenetics (EFI) in Lisbon, Portugal. Among the major scientific events, Omixon’s ...
(Date:5/2/2019)... (PRWEB) , ... May 01, 2019 , ... ... Board of Directors has appointed John Rakow, the Company’s General Counsel, as Interim ... Richman and Zac Apte, are currently on administrative leave. There will also be ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... ... The American Society of Gene & Cell Therapy (ASGCT) is excited to ... the presidential line of succession, at the 22nd Annual Meeting . Members of ... three-year term (2019-2021). , All five incoming members of the ASGCT Board of ...
(Date:4/8/2019)... , ... April 08, 2019 , ... US Capital ... a $15 million preferred equity investment in the privately held pharmaceutical company, S1 Biopharma ... drug, Lorexys, is targeted at female hypoactive sexual dysfunction disorder and is ready to ...
(Date:4/4/2019)... ... April 02, 2019 , ... Biomeme, Inc. , a ... latest field-ready solution for performing PCR, RT-PCR, qPCR, and Isothermal tests called ... Rosland Franklin, an English chemist and X-ray crystallographer who made significant contributions to ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced today ... with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility test ... of the $1.7 million already awarded by CARB-X. The additional $1.7M will enable ...
Breaking Biology Technology:
Cached News: